Cargando…

Large socioeconomic gap in period life expectancy and life years spent with complications of diabetes in the Scottish population with type 1 diabetes, 2013–2018

BACKGROUND: We report the first study to estimate the socioeconomic gap in period life expectancy (LE) and life years spent with and without complications in a national cohort of individuals with type 1 diabetes. METHODS: This retrospective cohort study used linked healthcare records from SCI-Diabet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Höhn, Andreas, McGurnaghan, Stuart J., Caparrotta, Thomas M., Jeyam, Anita, O’Reilly, Joseph E., Blackbourn, Luke A. K., Hatam, Sara, Dudel, Christian, Seaman, Rosie J., Mellor, Joseph, Sattar, Naveed, McCrimmon, Rory J., Kennon, Brian, Petrie, John R., Wild, Sarah, McKeigue, Paul M., Colhoun, Helen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371295/ https://www.ncbi.nlm.nih.gov/pubmed/35951518 http://dx.doi.org/10.1371/journal.pone.0271110

Ejemplares similares

The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes
por: Höhn, Andreas, et al.
Publicado: (2021)

Flash monitor initiation is associated with improvements in HbA(1c) levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study
por: Jeyam, Anita, et al.
Publicado: (2021)

Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004–2017
por: O’Reilly, Joseph E., et al.
Publicado: (2020)

Cohort profile: the Scottish Diabetes Research Network national diabetes cohort – a population-based cohort of people with diabetes in Scotland
por: McGurnaghan, Stuart J., et al.
Publicado: (2022)

Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland
por: Jeyam, Anita, et al.
Publicado: (2021)

Glycaemic control trends in people with type 1 diabetes in Scotland 2004–2016
por: Mair, Colette, et al.
Publicado: (2019)

Microvascular disease in diabetes and severe COVID-19 outcomes – Authors' reply
por: Colhoun, Helen M, et al.
Publicado: (2021)

Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland
por: McGurnaghan, Stuart J, et al.
Publicado: (2021)

Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis
por: McGurnaghan, S., et al.
Publicado: (2018)

Development and validation of a cardiovascular risk prediction model in type 1 diabetes
por: McGurnaghan, Stuart J., et al.
Publicado: (2021)

Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study
por: Bell, Samira, et al.
Publicado: (2017)

Biomarker panels associated with progression of renal disease in type 1 diabetes
por: Colombo, Marco, et al.
Publicado: (2019)

Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational study
por: Vadiveloo, Thenmalar, et al.
Publicado: (2018)

Genome-wide aggregated trans-effects on risk of type 1 diabetes: A test of the “omnigenic” sparse effector hypothesis of complex trait genetics
por: Iakovliev, Andrii, et al.
Publicado: (2023)

Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes
por: Colombo, Marco, et al.
Publicado: (2020)

Type 2 diabetes, socioeconomic status and life expectancy in Scotland (2012–2014): a population-based observational study
por: Walker, Jeremy, et al.
Publicado: (2017)

Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitus
por: Colombo, Marco, et al.
Publicado: (2019)

Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study
por: Ochs, Andreas, et al.
Publicado: (2019)

Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes
por: McKeigue, Paul M., et al.
Publicado: (2019)

Effect of serum sample storage temperature on metabolomic and proteomic biomarkers
por: Valo, Erkka, et al.
Publicado: (2022)

Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study
por: Wang, Huan, et al.
Publicado: (2023)

Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study
por: McKeigue, Paul M., et al.
Publicado: (2020)

Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study
por: McKeigue, Paul M., et al.
Publicado: (2021)

An Estimate of Lifetime Cognitive Change and Its Relationship with Diabetes Health in Older Adults with Type 1 Diabetes: Preliminary Results
por: Johnston, Harriet, et al.
Publicado: (2010)

Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme
por: Looker, H. C., et al.
Publicado: (2013)

Consequences of recurrent hypoglycaemia on brain function in diabetes
por: McCrimmon, Rory J.
Publicado: (2021)

Remembrance of things past: The consequences of recurrent hypoglycaemia in diabetes
por: McCrimmon, Rory J.
Publicado: (2022)

Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study
por: McKeigue, Paul M., et al.
Publicado: (2021)

Hypoglycemia in Type 1 Diabetes
por: McCrimmon, Rory J., et al.
Publicado: (2010)

Incidence of Hospitalization for Heart Failure and Case-Fatality Among 3.25 Million People With and Without Diabetes Mellitus
por: McAllister, David A., et al.
Publicado: (2018)

SGLT inhibitor adjunct therapy in type 1 diabetes
por: McCrimmon, Rory J., et al.
Publicado: (2018)

Response to Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901–907
por: Vistisen, Dorte, et al.
Publicado: (2021)

Impaired hypoglycaemia awareness in type 1 diabetes: lessons from the lab
por: McNeilly, Alison D., et al.
Publicado: (2018)

Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013
por: Read, Stephanie H., et al.
Publicado: (2016)

Mapping activities on climate and health to the essential public health operations (EPHO)
por: McGurnaghan, P, et al.
Publicado: (2023)

Effect of Socioeconomic Status on Mortality Among People With Type 2 Diabetes: A study from the Scottish Diabetes Research Network Epidemiology Group
por: Walker, Jeremy J., et al.
Publicado: (2011)

Scottish Student Life
Publicado: (1905)

Achieved Levels of HbA(1c) and Likelihood of Hospital Admission in People With Type 1 Diabetes in the Scottish Population: A study from the Scottish Diabetes Research Network Epidemiology Group
por: Govan, Lindsay, et al.
Publicado: (2011)

Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study
por: McKeigue, Paul M, et al.
Publicado: (2022)

Risk for rheumatic disease in relation to ethnicity and admixture
por: Molokhia, Mariam, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_hiihf93d5bf44gef7jd9qnvj9i